GC
INO icon

GMT Capital’s Inovio Pharmaceuticals INO Stock Holding History

GMT Capital’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139K Hold
126,119
– – 0.01% 64
2026
Q1 		$219K Buy
+126,119
New +$208K 0.01% 71
2025
Q4 		– Sell
-126,119
Closed -$295K – 53
2025
Q3 		$295K Hold
126,119
– – 0.01% 64
2025
Q2 		$257K Hold
126,119
– – 0.01% 69
2025
Q1 		$206K Sell
126,119
-2
-0% -$4 0.01% 67
2024
Q4 		$231K Hold
126,121
– – 0.01% 55
2024
Q3 		$729K Buy
+126,121
New +$1.04M 0.03% 58
2023
Q4 		– Sell
-126,125
Closed -$589K – 72
2023
Q3 		$589K Hold
126,125
– – 0.02% 89
2023
Q2 		$676K Buy
+126,125
New +$1.02M 0.03% 78

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

GMT Capital's INO Position: Q2 2026 in Review

GMT Capital held its Inovio Pharmaceuticals (INO) position steady in Q2 2026 at 126,119 shares worth $139K. The position accounts for 0.01% of the portfolio, ranked #64.

GMT Capital first reported a position in INO in Q2 2023 and has held it in 9 quarters since. The position peaked at $729K in Q3 2024. 103 funds tracked by Wall St. Rank hold INO as of Q2 2026.

  • GMT Capital held 126,119 shares of Inovio Pharmaceuticals worth $139K as of Q2 2026.
  • GMT Capital left its Inovio Pharmaceuticals share count unchanged in Q2 2026.
  • Inovio Pharmaceuticals made up 0.01% of GMT Capital's portfolio in Q2 2026, its #64 holding.
  • GMT Capital first reported a position in Inovio Pharmaceuticals in Q2 2023 and has held it in 9 quarters since.
  • GMT Capital's Inovio Pharmaceuticals position peaked at $729K in Q3 2024.
  • 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2026.

Based on GMT Capital's 13F filing for Q2 2026, filed 14 Aug 2026.